1.
Galectin-3在非小细胞肺癌组织中的表达及与临床病理特征的关系
Relationship between the expression of Galectin-3 in non-small cell lung cancer tissue and clinicopathological features
| Characteristic | n | Galectin-3 | ||||
| - | + | Positive (%) | χ2 | P | ||
| SCC: squamous cell carcinoma; AC: adenocarcinoma. | ||||||
| Sex | 0.113 | 0.737 | ||||
| Male | 34 | 5 | 29 | 85.3 | ||
| Female | 28 | 5 | 23 | 82.1 | ||
| Age (yr) | 0.22 | 0.639 | ||||
| ≤50 | 33 | 6 | 27 | 81.8 | ||
| > 50 | 29 | 4 | 25 | 86.2 | ||
| Histological | 0.012 | 0.911 | ||||
| SCC | 32 | 5 | 27 | 86.2 | ||
| AC | 30 | 5 | 25 | 80.8 | ||
| Degree of differentiation | 8.577 | 0.014 | ||||
| Well differentiation | 24 | 8 | 16 | 66.7 | ||
| Moderate differentiation | 17 | 1 | 16 | 94.1 | ||
| Poor differentiation | 21 | 1 | 20 | 95.2 | ||
| p-TNM status | 5.287 | 0.021 | ||||
| Ⅰa-Ⅱb | 29 | 8 | 21 | 72.4 | ||
| Ⅲa-Ⅳb | 33 | 2 | 31 | 93.9 | ||